切换至 "中华医学电子期刊资源库"

中华乳腺病杂志(电子版) ›› 2010, Vol. 04 ›› Issue (03) : 252 -258. doi: 10.3877/cma.j.issn.1674-0807.2010.03.004

乳腺癌保留乳房手术和前哨淋巴结检测专题

前哨淋巴结活检指导保留乳房手术患者行选择性腋窝淋巴结清除术的研究
陈翔1,2, 王水1, 刘晓安1, 凌立君1, 丁强1, 査小明1,()   
  1. 1.210029 南京,南京医科大学第一附属医院乳腺外科
    2.214200 江苏 宜兴,宜兴市人民医院普外科
  • 收稿日期:2010-03-22 出版日期:2010-06-01
  • 通信作者: 査小明
  • 基金资助:
    卫生部“十一五”支撑计划(AC08);江苏省自然科学基金项目(BK2008476;BK2009438);江苏省科教兴卫工程项目(RC2007054)

Study of sentinel lymph node biopsy in directing selective axillary lymph node dissection in patients receiving breast-conserving therapy

Xiang CHEN, Shui WANG, Xiao-an LIU, Li-jun LING, Qiang Ding, Xiao-ming ZHA()   

  • Received:2010-03-22 Published:2010-06-01
  • Corresponding author: Xiao-ming ZHA
引用本文:

陈翔, 王水, 刘晓安, 凌立君, 丁强, 査小明. 前哨淋巴结活检指导保留乳房手术患者行选择性腋窝淋巴结清除术的研究[J/OL]. 中华乳腺病杂志(电子版), 2010, 04(03): 252-258.

Xiang CHEN, Shui WANG, Xiao-an LIU, Li-jun LING, Qiang Ding, Xiao-ming ZHA. Study of sentinel lymph node biopsy in directing selective axillary lymph node dissection in patients receiving breast-conserving therapy[J/OL]. Chinese Journal of Breast Disease(Electronic Edition), 2010, 04(03): 252-258.

目的

研究通过前哨淋巴通道(SLC)行前哨淋巴结活检(SLNB)以指导保留乳房手术(breast-conserving therapy,BCT)患者行选择性腋窝淋巴结清除术(ALND)的可行性。

方法

采用非随机对照研究,在BCT 患者中采用联合示踪法通过SLC 行SLNB。对术中检出的前哨淋巴结(SLN)行细胞印片和冰冻切片检查,根据SLN 的术中病理结果行选择性ALND,其中SLN 阳性、行ALND 者为A 组,SLN 阴性仅行SLNB者为B组。定性资料的比较选用χ2 检验,两组均数的比较采用t检验。

结果

2009年1月至2009年12月采用联合示踪法行SLNB的BCT 患者共43例,检出42例,A 组28例,B组14例。两组患者的SLC 均被显影。每例患者被检出SLN 1~3枚,平均1.4枚,共被检出59枚。SLNB检出率为97.7%(42/43)。术后病理检查共检出阳性SLN 29例,其中术中细胞印片、冰冻切片及二者联合病理检测分别检出阳性淋巴结27、27、28例。A 组ALND 相关并发症发生率明显高于B组(P=0.003)。

结论

通过SLC行SLNB有助于准确定位SLN,能够指导BCT 患者行选择性ALND,降低术后并发症。

Objective

To study the possibility of selective axillary lymph node dissection(ALND)according to the sentinel lymph node biopsy(SLNB)technique through sentinel lymph channel (SLC)in patients receiving breast-conserving treatment(BCT).

Methods

In this non-randomized study,the SLNB technique with combinative tracer method through SLC was adopted in all patients receiving BCT.All sentinel lymph nodes(SLNs)were investigated by touch cytology and frozen section.According to the intraoperative pathologic results of SLNs,all patients received ALND or SLNB only.Patients in Group A received ALND when the SLNs were positive,patients in Group B received SLNB only in case of negative SLNs.The data were analyzed by SPSS 10.0.Chi-square test was used for comparison of the qualitative data and t test was used to compare the means between the two groups.

Results

From Jan.2009 to Dec.2009,43 patients received BCT and SLNB with combinative tracer method.A total of 42 patients were identified with SLNs(28 patients in Group A and 14 patients in Group B).Patients'SLCs of both groups were observed.The number of SLN harvested by SLNB was 1~3(average,1.4)per patient.A total of 59 were detected.The dissection rate of SLNB was 97.7% (42/43).We found positive SLN in 29 patients.The intraoperative positive SLNs detected by touch cytology,frozen section and joint pathological detection were 27,27 and 28,respectively.The ALND-related complication rate of Group A was higher than that of Group B (P =0.003).

Conclusion

SLNB through SLC helps to locate SLN accurately,direct selective ALND and decrease complications.

表1 两组患者的一般临床资料比较
图1 SPECT 核素淋巴显影 a:1~6 min时,前哨淋巴通道(SLC)及前哨淋巴结(SLN)的显影情况;b:20~60 min时,SLC及SLN 的显影情况;→:乳晕注射处;←:显影的前哨淋巴结;连接两点之间的通道即为前哨淋巴通道。
图2 蓝染的前哨淋巴通道和前哨淋巴结 术中寻及热点淋巴结后解剖周围蓝染管道,可见染料经蓝染的前哨淋巴通道进入前哨淋巴结(a,b)。
图3 B组(保留乳房手术+前哨淋巴结活检)乳腺癌患者术后外观 a:侧面(←所示前哨淋巴结活检切口);b:正面
表2 A、B两组的术后并发症比较 (例)
[1]
Krag DN,Weaver DL,Alex JC,et al.Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe.Surg Oncol,1993,2:335-339.
[2]
刘发生,刘瑜,吴成辉.106例Ⅰ、Ⅱ期乳腺癌的保留乳房治疗体会.中华乳腺病杂志:电子版,2009,3:346-349.
[3]
王水,刘晓安,赵佳,等.染料法乳腺癌前哨淋巴通道的研究.中华外科杂志,2006,44:748-750.
[4]
Mc Masters KM,Tuttle TM,Carlson DJ,et al.Sentinel lymph node biopsy for breast cancer:a suitable alternative to routine axillary dissection in multi-institutional practice when optimal technique is used.JClin Oncol,2000,18:2560-2566.
[5]
Derossis AM,Fey J,Yeung H,et al.A trend analysis of the relative value of blue dye and isotope localization in 2000 consecutive cases of sentinel node biopsy for breast cancer.J Am Coll Surg,2001,193:473-478.
[6]
Choi YJ,Yun HR,Yoo KE,et al.Intraoperative examination of sentinel lymph nodes by ultrarapid immunohistochemistry in breast cancer.Jpn J Clin Oncol,2006,36:489-493.
[7]
Upender S,Mohan H,Handa U,et al.Intraoperative evaluation of sentinel lymph nodes in breast carcinoma by imprint cytology,frozen section and rapid immunohistochemistry.Diagn Cytopathol,2009,37:871-875.
[8]
Krishnamurthy S,Meric Bernstam F,Lucci A,et al.A prospective study comparing touch imprint cytology,frozen section analysis,and rapid cytokeratin immunostain for intraoperative evaluation of axillary sentinel lymph nodes in breast cancer.Cancer,2009,115:1555-1562.
[9]
Julian TB,Blumencranz P,Deck K.Novel Intraoperative molecular test for sentinel lymph node metastases in patients with early-stage breast cancer.J Clin Oncol,2008,26:3338-3345.
[10]
Lee IK,Lee HD,Jeong J,et al.Intraoperative examination of sentinel lymph nodes by immunohistochemical staining in patients with breast cancer.Eur J Surg Oncol,2006,32:405-409.
[11]
Purushotham AD,Upponi S,Klevesath MB,et al.Morbidity after sentinel lymph node biopsy in primary breast cancer:results from a randomized controlled trial.J Clin Oncol,2005,23:4312-4321.
[12]
Mansel RE,Fallowfield L,Kissin M,et al.Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer:the ALMANAC trial.J Natl Cancer Inst,2006,98:599-609.
[1] 吴意赟, 蔡婷, 许华宁, 强也, 赵淳. 联合经皮和经静脉超声造影对乳腺癌前哨淋巴结的诊断价值[J/OL]. 中华医学超声杂志(电子版), 2020, 17(12): 1168-1172.
[2] 刘炎东, 李恒宇. 新辅助化疗后乳腺癌局部区域的分期评估和治疗的降阶梯策略[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(03): 146-151.
[3] 唐朝易, 韦德飞, 卿佳林. 容积替代技术在乳腺癌保留乳房手术中的应用[J/OL]. 中华乳腺病杂志(电子版), 2022, 16(04): 247-252.
[4] 乌帆, 王耕, 姚方辉, 柴松山, 李文仿. 1~2枚腋窝前哨淋巴结转移的乳腺癌患者非前哨淋巴结转移影响因素分析[J/OL]. 中华乳腺病杂志(电子版), 2022, 16(02): 91-95.
[5] 陈志强, 凌煜玮, 康骅. 早期乳腺癌保留乳房手术中的组织缺损修复[J/OL]. 中华乳腺病杂志(电子版), 2021, 15(03): 169-173.
[6] 陈彦博, 胡婷婷, 陈凯, 苏逢锡. 乳腺癌患者保留乳房手术后复发、转移危险因素分析[J/OL]. 中华乳腺病杂志(电子版), 2021, 15(03): 143-151.
[7] 秦兴松, 郑新宇. 乳腺癌前哨淋巴结活组织检查染色与标记的方法[J/OL]. 中华乳腺病杂志(电子版), 2020, 14(06): 375-378.
[8] 尹亮, 张晴, 肖秀娣, 钱晓芹. 经皮对比增强超声在乳腺癌前哨淋巴结术前定位及转移风险评估中的临床应用价值[J/OL]. 中华乳腺病杂志(电子版), 2020, 14(06): 331-336.
[9] 金立亭, 冯尧军. 治疗性缩乳成形术在乳房肥大患者乳腺癌保留乳房手术中的应用[J/OL]. 中华乳腺病杂志(电子版), 2020, 14(01): 58-61.
[10] 刘晓静, 杨柳春, 进淑娟, 毕艳, 韩小伟, 左思, 孟迪, 李建鹏, 栾忠良, 夏玉婷, 黄焰. 乳腺癌患者生存与复发的随访报告:一项单中心回顾性研究[J/OL]. 中华乳腺病杂志(电子版), 2019, 13(05): 270-276.
[11] 全国Intrabeam系统术中放射治疗临床协作组专家委员会. 乳腺癌Intrabeam系统术中放射治疗临床操作指南[J/OL]. 中华乳腺病杂志(电子版), 2019, 13(04): 193-197.
[12] 崔世恩, 凌飞海, 黄志华, 马士辉. 新辅助治疗对雌激素受体低表达/人类表皮生长因子受体2阳性乳腺癌腋窝淋巴结状态的影响[J/OL]. 中华普通外科学文献(电子版), 2020, 14(03): 230-234.
[13] 杨林, 包国强, 董彦明, 杨平, 霍良宝, 张铎, 彭书甲. 乳腺癌腔镜下前哨淋巴结活检的临床应用效果[J/OL]. 中华普外科手术学杂志(电子版), 2022, 16(02): 154-157.
[14] 王晶, 朱宇, 胡永胜, 李霞, 贺菊, 李旭, 柳滿然. 超声造影结合细针穿刺活检对乳腺癌前哨淋巴结的诊断效率[J/OL]. 中华普外科手术学杂志(电子版), 2021, 15(05): 550-553.
[15] 杨小军, 唐海利, 樊东, 邱波, 赵华栋, 包国强. 乳腺癌非前哨淋巴结转移的预测模型构建[J/OL]. 中华普外科手术学杂志(电子版), 2020, 14(06): 612-615.
阅读次数
全文


摘要